Biomerica Inc. Files Definitive Proxy Statement
Ticker: BMRA · Form: DEF 14A · Filed: Sep 30, 2024 · CIK: 73290
| Field | Detail |
|---|---|
| Company | Biomerica INC (BMRA) |
| Form Type | DEF 14A |
| Filed Date | Sep 30, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.08, $500 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, regulatory-filing
TL;DR
BIOMERICA files proxy statement - shareholders vote soon.
AI Summary
Biomerica Inc. filed its definitive proxy statement (DEF 14A) on September 30, 2024, for its fiscal year ending May 31, 2024. The filing details information related to the company's annual meeting and matters to be voted on by shareholders. Biomerica Inc. is involved in the in vitro and in vivo diagnostic substances industry.
Why It Matters
This filing provides shareholders with crucial information needed to make informed decisions regarding company governance and voting at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not inherently introduce new risks.
Key Players & Entities
- BIOMERICA INC (company) — Registrant
- 0001493152-24-038820 (filing_id) — Accession Number
- 20240930 (date) — Filing Date
- 0531 (date) — Fiscal Year End
- 17571 VON KARMAN AVENUE (address) — Business Address
- IRVINE (location) — City
- 9493792875 (phone_number) — Business Phone
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing details on matters to be voted upon.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on September 30, 2024.
What is Biomerica Inc.'s fiscal year end?
Biomerica Inc.'s fiscal year ends on May 31.
What is Biomerica Inc.'s primary business classification?
Biomerica Inc. is classified under 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' with SIC code 2835.
Where is Biomerica Inc. headquartered?
Biomerica Inc.'s business address is located at 17571 Von Karman Avenue, Irvine, CA 92614.
Filing Stats: 4,711 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2024-09-30 17:00:08
Key Financial Figures
- $0.08 — ion of the holders of our Common Stock, $0.08 par value, entitled to notice of and to
- $500 million — a market capitalization of approximate $500 million. From March 2017 to June 2020, David al
Filing Documents
- formdef14a.htm (DEF 14A) — 552KB
- formdef14a_001.jpg (GRAPHIC) — 28KB
- 0001493152-24-038820.txt ( ) — 592KB
: Gender Identity
Part I: Gender Identity Directors 2 3 - -
: Demographic Background
Part II: Demographic Background African American or Black - - - - Alaskan Native or Native American - - - - Asian - - - - Hispanic or Latinx - - - - Native Hawaiian or Pacific Islander - - - - White 2 3 - - Two or More Races or Ethnicities - - - - LGBTQ+ - - - - Did Not Disclose Demographic Background - - - - Vote Required and Board Recommendation Each director nominee shall be elected by a plurality vote of the stockholders of the Company present in person or by proxy at the Annual Meeting and entitled to vote. Our Board Recommends that the Stockholders Vote “FOR” the Election of Each of the Five Director Nominees. EXECUTIVE OFFICERS The following table sets forth the names, ages and positions of our executive officers: Name Age Position(s) Zackary Irani 58 Chief Executive Officer Allen Barbieri 66 Executive Vice Chairperson Gary Lu 44 Chief Financial Officer The following provides certain biographical information with respective to each of our executive officers who is not a director. Zackary Irani Mr. Zackary Irani’s background is discussed above under the heading “Background of Nominees.” Allen Barbieri Mr. Allen Barbieri’s background is discussed above under the heading “Background of Nominees.” Gary Lu Mr. Gary Lu has served as the Chief Financial Officer of the Company since March 2023. Mr. Gary Lu brings over 20 years